FUNDAMENTALS · Fundamentals · US Healthcare

AptarGroup (ATR) Fundamentals 2026 — P/E 21.9x, Revenue Analysis | SniperIQ

AptarGroup (ATR) is a US-listed Healthcare company in Medical - Instruments & Supplies with a market capitalization of $8.3B, trading at

29.37 on the NYSE. This SniperIQ fundamentals page covers AptarGroup's valuation (P/E 21.9x, P/B 3.2x), profitability (net margin 10.0%), revenue (
.8B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap$8.3B
P/E (TTM)21.9x
Net Margin10.0%
Revenue (FY25)
.8B

Full research coverage

Frequently Asked Questions

What is AptarGroup's market cap?

AptarGroup (ATR) has a market capitalization of approximately $8.3B, trading at

29.37 on the NYSE. Market cap moves with the live share price.

What is AptarGroup's P/E ratio?

AptarGroup's trailing twelve-month P/E ratio is 21.9x, with a price-to-book (P/B) of 3.2x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is AptarGroup?

AptarGroup runs a net profit margin of 10.0%, a gross margin of 29.0%, and an operating margin of 13.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does AptarGroup generate?

AptarGroup reported revenue of

.8B for fiscal year 2025, with net income of
93M and earnings per share (EPS) of 5.97. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does AptarGroup pay a dividend?

AptarGroup offers a trailing dividend yield of about 1.5%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is AptarGroup financially healthy?

AptarGroup carries a debt-to-equity ratio of 0.54x and a current ratio of 1.66x, with a market beta of 0.39. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is AptarGroup a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For AptarGroup (ATR) the key facts are: market cap $8.3B, P/E 21.9x, revenue

.8B, 52-week range 103.23-164.28. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track AptarGroup's full fundamentals live

Get AptarGroup's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.